Andrew Pasternak
Independent ChairmanMr. Andrew Pasternak, also known as Andy, is Independent Chairman of Context Therapeutics Inc. from January 2025. Mr. Pasternak is Chief Strategy Officer of Kardigan, Inc. from January 2026. Mr. Pasternak was Independent Director of Endo Inc. from April 23, 2024 until July 31, 2025. He serves as Director at Endo International plc. Mr. Pasternak is a biopharmaceutical executive and expert with experience and served as an Advisory Partner at Bain & Company, a leading global consulting firm rom March 2024 to December 2025 and also serves as Chairman of the Board of Directors of Context Therapeutics, an oncology-focused biotechnology company since January 2025. Most recently. Mr. Pasternak served as Executive Vice President, Chief Strategy Officer at Horizon Therapeutics Plc from November 2019 until its acquisition by Amgen Inc. in October 2023. Prior to joining Horizon in 2019. Mr. Pasternak was a senior partner at Bain & Company, where he served as Head of the Healthcare Practice in the Americas. He was an analyst in the Investment Banking division of Chemical Securities, Inc. (now part of J.P. Morgan). Mr. Pasternak is also an Adjunct Lecturer in the Healthcare Program at the Kellogg School of Management. He serves on the board of directors of Make-A-Wish, Illinois Chapter. Mr. Pasternak received his B.A. in economics from Northwestern University and an M.B.A. from the University of Chicago.
Positions
- Company NameContext Therapeutics Inc.Stock CodeCNTXPositionIndependent ChairmanColleagues
- MAMartin A. LehrCo-Founder, President, CEO & Director
- JMJennifer Minai-AzaryCFO & Treasurer
- ACAlex C. LevitChief Legal Officer & Corporate Secretary
- CBChristopher BeckSenior Vice President of Operations
- JLJeffrey LiebmanAssociate Director of Accounting
- JEJennifer Evans StaceyIndependent Director
- LBLinda B. WestIndependent Director
- KLKaren L. SmithIndependent Director
